Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
340.22
-4.63 (-1.34%)
Feb 21, 2025, 4:00 PM EST - Market closed
Medpace Holdings Revenue
In the year 2024, Medpace Holdings had annual revenue of $2.11B with 11.84% growth. Medpace Holdings had revenue of $536.59M in the quarter ending December 31, 2024, with 7.66% growth.
Revenue (ttm)
$2.11B
Revenue Growth
+11.84%
P/S Ratio
4.99
Revenue / Employee
$357,467
Employees
5,900
Market Cap
10.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
| Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
MEDP News
- 22 hours ago - The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation - Accesswire
- 10 days ago - Medpace Holdings, Inc. (MEDP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 16 days ago - Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential - Seeking Alpha
- 19 days ago - The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud - Accesswire
- 22 days ago - Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 24 days ago - Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 4 weeks ago - MoneyShow's Best Investment Ideas For 2025: Part 6 - Seeking Alpha